ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,504.45
      -0.26%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Incyte Corporation (INCY)

      7. Incyte Corporation (INCY) News

      INCY

      Incyte (INCY)

      Incyte Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INCY
      DateTimeSourceHeadlineSymbolCompany
      12/14/20201:15AMBusiness WireIncyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi®) as a Treatment for Patients with COVID-19 Associ...NASDAQ:INCYIncyte Corporation
      12/11/20202:01PMPR Newswire (US)Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journa...NASDAQ:INCYIncyte Corporation
      12/09/20208:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
      12/08/20208:40AMBusiness WireIncyte meldet Ergebnisse der Behandlung mit Parsaclisib, die bei Patienten mit rezidivierten oder refraktären B-Zell-Nicht-H...NASDAQ:INCYIncyte Corporation
      12/07/202010:46PMBusiness WireIncyte rend publics les résultats du traitement par Parsaclisib : un taux élevé de réponses rapides et durables chez les ...NASDAQ:INCYIncyte Corporation
      12/07/202010:00AMBusiness WireIncyte Announces Parsaclisib Treatment Results in High Rate of Rapid & Durable Responses in Patients with Relapsed or Refract...NASDAQ:INCYIncyte Corporation
      12/07/202010:00AMBusiness WireData Evaluating Tafasitamab with & without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020NASDAQ:INCYIncyte Corporation
      12/04/202012:30PMBusiness WireIncyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi®) Significantly Improved Outcomes in Patients with...NASDAQ:INCYIncyte Corporation
      11/19/20206:14PMDow Jones NewsEli Lilly, Incyte Say FDA Grants EUA for BaricitinibNASDAQ:INCYIncyte Corporation
      11/19/20205:20PMPR Newswire (US)Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19NASDAQ:INCYIncyte Corporation
      11/18/20204:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20204:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/18/20204:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/16/20204:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/12/20204:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/12/20208:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
      11/11/20204:02PMBusiness WireXencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with PlamotamabNASDAQ:INCYIncyte Corporation
      11/10/20204:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/09/20208:00AMBusiness WireData from Incyte’s Oncology Portfolio Accepted for Presentation at the Society for Immunotherapy of Cancer 2020 Annual Meet...NASDAQ:INCYIncyte Corporation
      11/05/20204:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INCYIncyte Corporation
      11/05/20207:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INCYIncyte Corporation
      11/05/20207:00AMBusiness WireIncyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
      11/05/20206:30AMBusiness WirePlus de 40 abstracts du portefeuille d'oncologie d'Incyte sont acceptés pour présentation lors du 62e congrès annuel virtu...NASDAQ:INCYIncyte Corporation
      11/05/20206:19AMBusiness WireMehr als 40 Abstracts aus dem Onkologieportfolio von Incyte zur Präsentation auf der virtuellen 62. ASH-Jahrestagung angenom...NASDAQ:INCYIncyte Corporation
      11/04/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      11/04/20203:55PMBusiness WireMore than 40 Abstracts from Incyte’s Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual MeetingNASDAQ:INCYIncyte Corporation
      11/02/20202:00PMPR Newswire (US)ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant® in Rheumatoid ArthritisNASDAQ:INCYIncyte Corporation
       Showing the most relevant articles for your search:NASDAQ:INCY